Fund Management

Leveraged loans in Europe are being repaid earlier than ever at the moment. This is causing problems for managers of collateralised loan obligation funds. Deal Mechanic explains why

David Chamberlain, the former managing director of private equity at Swiss alternative asset manager Unigestion, has joined Zurich-based placement agent Palomar Capital Advisors as managing director.

Citigroup Venture Capital has agreed to buy the non-memory division of Hynix Semiconductor after more than a year of negotiations.

The Boston-based growth equity specialist has recapitalised Global Cash Access, a Las Vegas company that provides ATMs and other services to the ‘gaming industry.’

Though venture capital activity is dwarfed by its neighbour to the south, Canada has taken steps toward realising its full entrepreneurial potential. By Art Janik

In the past, distressed debt investors have swooped on targets in the US with considerable success. Europe, and particularly Germany, are now looking increasingly inviting too. Andy Thomson reports

Weak returns among Canada's heavily government-subsidised labour-sponsored investment funds bring into question their future. Independent venture firms won't shed tears at their demise

Editor's letter 2004-07-02 Staff Writer Happy times are here again for the leveraged finance markets. After three years of bankruptcies and deteriorating credit conditions, companies are having an easier time paying back their loans. According to Moody's, the junk bond default rate dropped to 3.4 percent in

Venture debt enjoys little of the upside of venture capital, but most of its downside. No wonder this remains a niche play. But with the recent uptick in deal activity in the past twelve months, the handful of venture debt lenders are shifting gears as demand for their capital accelerates. Art Janik provides an overview of the current state of the venture debt market.

A new private equity fund, led by a retired Hicks Muse partner, will seek opportunities in the chronically inefficient healthcare royalties market. David Snow examines this alternative, alternative strategy, and checks in with the only other private equity firm to have executed it – New York's Paul Capital Partners